MIAN
XPH icon

Mariner Independent Advisor Network’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Mariner Independent Advisor Network’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-29,903
Closed -$1.25M – 344
2017
Q1 		$1.25M Buy
+29,903
New +$1.22M 0.15% 89

Other funds holding XPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return

Mariner Independent Advisor Network's XPH Position: Q2 2017 in Review

Mariner Independent Advisor Network sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2017, closing a stake of 29,903 shares — an estimated $1.25M sold.

Mariner Independent Advisor Network first reported a position in XPH in Q1 2017 and held it in 1 quarter. The position peaked at $1.25M in Q1 2017. 80 funds tracked by Wall St. Rank hold XPH as of Q2 2017.

  • Mariner Independent Advisor Network reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 29,903 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2017, an estimated $1.25M.
  • Mariner Independent Advisor Network first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2017 and held it in 1 quarter.
  • Mariner Independent Advisor Network's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.25M in Q1 2017.
  • 80 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2017.

Based on Mariner Independent Advisor Network's 13F filing for Q2 2017, filed 16 Aug 2017.